Literature DB >> 1132118

Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture.

W J Oliver, E L Cohen, J V Neel.   

Abstract

The Yanomamo Indians are an unacculturated tribe inhabiting the tropical equatorial rain forest of northern Brazil and southern Venezuela who do not use salt in their diet. The group therefore presented an unusual opportunity to study the hormonal regulation of sodium metabolism in a culture with life-long extreme restriction of dietary sodium, with parallel observations on blood pressure. Blood pressures increased from the first to second decade but, in constrast to civilized populations, do not systematically increase during subsequent years of life. In twenty-four hour urine collections on adult male Indians, excretion of sodium averaged only 1 plus or minus 1.5 (SD) mEq. Simultaneous plasma renin activities were elevated and comparable to those of civilized subjects placed for brief periods on 10 mEq sodium diets. Similarly, excretion rates of aldosterone equaled those of acculturated subjects on low sodium diets. The findings suggest that the hormonal adjustments to life-long low sodium intakes are similar to those achieved in acute sodium restriction of civilized man. Parenthetically, these elevated levels of aldosterone and renin were probably the norm for man during much of human evolution and suggest that the values observed in civilized controls are depressed by an excessive salt intake in contemporary diets.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1132118     DOI: 10.1161/01.cir.52.1.146

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  79 in total

Review 1.  Impact of dietary sodium on cardiovascular disease morbidity and mortality.

Authors:  Michael H Alderman; Hillel W Cohen
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

2.  Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.

Authors:  Alessia Buglioni; Valentina Cannone; Alessandro Cataliotti; S Jeson Sangaralingham; Denise M Heublein; Christopher G Scott; Kent R Bailey; Richard J Rodeheffer; Paolo Dessì-Fulgheri; Riccardo Sarzani; John C Burnett
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

3.  Salt causes aging-associated hypertension via vascular Wnt5a under Klotho deficiency.

Authors:  Wakako Kawarazaki; Risuke Mizuno; Mitsuhiro Nishimoto; Nobuhiro Ayuzawa; Daigoro Hirohama; Kohei Ueda; Fumiko Kawakami-Mori; Shigeyoshi Oba; Takeshi Marumo; Toshiro Fujita
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

Review 4.  Challenges to potassium metabolism: internal distribution and external balance.

Authors:  Gerhard Giebisch
Journal:  Wien Klin Wochenschr       Date:  2004-06-30       Impact factor: 1.704

Review 5.  Stress and hypertension.

Authors:  P Mustacchi
Journal:  West J Med       Date:  1990-08

6.  By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations.

Authors:  M R Law; C D Frost; N J Wald
Journal:  BMJ       Date:  1991-04-06

Review 7.  Salt restriction for the prevention of cardiovascular disease.

Authors:  Dieter Klaus; Joachim Hoyer; Martin Middeke
Journal:  Dtsch Arztebl Int       Date:  2010-07-02       Impact factor: 5.594

Review 8.  Maintaining K+ balance on the low-Na+, high-K+ diet.

Authors:  Ryan J Cornelius; Bangchen Wang; Jun Wang-France; Steven C Sansom
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-06

Review 9.  High salt intake as a multifaceted cardiovascular disease: new support from cellular and molecular evidence.

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

Review 10.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.